Silexion Therapeutics SLXN shares plunge 857 after earnings miss with EPS falling 225 below estimates CRI Carters tops Q4 2025 EPS estimates posts 19 percent year over year revenue growth shares rise 106 percent What Codere CDRO disclosed about cash conversion Q4 2025 Below Expectations KB KB delivers 94 percent Q4 2025 EPS beat even as shares edge down 05 percent today LSB Industries LXU Stock Gap Down Watch Slight Rise 20260420 Mayville MEC Stock Resistance Test 100 20260420 BGMS BioGreen Med Q3 2024 earnings top analyst projections shares climb 178 percent in todays trading Air Products and Chemicals Inc APD Cocoa Air Separation Unit Expansion Underscores Balanced Growth Portfolio Strategy